Erectile Dysfunction as An Early Indicator of Systemic Oxidative Stress and Endothelial Cell Dysfunction
Wednesday, 19 November 2003
Introduction and Objective: Penile erection involves increased arterial inflow and decreased venous outflow secondary to relaxation of smooth muscle both within the wall of the small penile arteries and the corpus cavernosum.
read more
|
Studies Indicate Patients Prefer Tadalafil, Vardenafil Over Sildenafil
Monday, 17 November 2003
FRANKFURT (Reuters) - Patients with erectile dysfunction prefer rival drugs over the pioneering treatment, Pfizer's Viagra (sildenafil), show two studies to be presented at a meeting of sexual medicine researchers.
read more
|
Anti-impotence Nasal Spray Shows Promise in Trial
Monday, 03 November 2003
NEW YORK (Reuters) - An experimental anti-impotence nasal spray achieved its primary goals in a mid-stage clinical trial, the drug's maker said on Monday.
read more
|
Impotence Drug Maker Fights 'Dirty Old Men' Image
Wednesday, 29 October 2003
LONDON (Reuters) -The maker of a new drug for erectile dysfunction said on Wednesday it was backing a controversial photographic exhibition to ensure users are not seen as "dirty old men."
read more
|
Receptor Gene Plays Key Role in Regulating Puberty
Thursday, 23 October 2003
NEW YORK (Reuters Health) - An intact G protein-coupled receptor gene (GPR54) seems to be necessary for normal puberty to occur in both humans and mice, according to a report published in the October 23rd issue of The New England Journal of Medicine.
read more
|
New Approaches to Treatment of Chronic Orchialgia Suggested
Tuesday, 14 October 2003
Diagnosis and treatment of chronic orchialgia challenges many urologists. Drs. Masarani and Cox reviewed their approaches in the March issue of British Journal of Urology International.
read more
|
Lilly, ICOS yet to Provide Data to FDA on Cialis for Erectile Dysfunction
Friday, 10 October 2003
NEW YORK (Reuters) - Eli Lilly and Co. and ICOS Corp. said on Friday they have not yet provided data on their impotence treatment Cialis requested by U.S. regulators, but still expect to launch the Viagra rival in the second half of 2003.
read more
|
Vardenafil Beats Sildenafil Study
Thursday, 09 October 2003
LONDON (Reuters) - Nearly half of men who did not respond to sildenafil (Viagra) achieved successful sexual intercourse when given Bayer AG and GlaxoSmithKline Plc's rival drug vardenafil (Levitra), researchers said on Thursday.
read more
|
Other Benign Headache Types Linked to Headache Associated with Sexual Activity
Tuesday, 30 September 2003
NEW YORK (Reuters Health) - Headaches classified by the International Headache Society as "headache with sexual activity (HSA)" commonly occur in patients with histories of other benign headache types.
read more
|
Italian and British Men Talk More Sex with Doctors
Monday, 29 September 2003
LONDON (Reuters) - Italian and British men are more at ease talking to doctors about their sexual health than their Austrian, German and Dutch neighbors, according to a survey released on Monday.
read more
|
Comparison of Erectile Function and Treatment Satisfaction in Patients Receiving Sildenafil. Intracvernosal PGE-1 and Penile Implant Surgery for Erectile Dysfunction
Friday, 29 August 2003
Introduction and Objective: To compare erectile function and satisfaction in patients receiving treatment for erectile dysfunction (ED) with sildenafil, intracavernous injection (ICI) and penile implant surgery (IPP) utilizing erectile function domain (EFD) and EDITS questionnaire.
read more
|
Cialis Impotence Drug Gets Approval in Mexico
Thursday, 28 August 2003
NEW YORK (Reuters) - The impotence drug Cialis, which is awaiting regulatory approval in the United States, has been approved for sale in Mexico, the drug's makers said on Thursday.
read more
|
U.S. Approves Levitra from Glaxo, Bayer, Rival to Viagra
Wednesday, 20 August 2003
WASHINGTON (Reuters) - GlaxoSmithKline Plc and Bayer AG won U.S. approval on Tuesday to sell Levitra for treating impotence, the first rival to the popular Viagra in the world's most profitable drug market.
read more
|
One Third of Older Men Report Erectile Dysfunction
Monday, 04 August 2003
NEW YORK (Reuters Health) - Erectile dysfunction is common among older men--affecting about one in three--and the prevalence increases with age, but changing just a few lifestyle factors can dramatically reduce the risk, according to a new report.
read more
|
Brazil Bans Ads for Anti-impotence Drugs
Friday, 25 July 2003
RIO DE JANEIRO (Reuters) - Ads for Viagra (sildenafil), like those that featured soccer legend Pele, got the boot on Thursday when Brazil banned advertising of all anti-impotence phosphodiesterase inhibitors, citing fears they were stimulating Brazilians to excessive and inappropriate use of the medicines.
read more
|
Erectile Dysfunction (ED) 
